Latest debt-to-equity ratio
Iovance Biotherapeutics Debt-to-equity ratio
Direct answer
Iovance Biotherapeutics's debt-to-equity ratio is 6.25%.
The verified market snapshot reports 6.25%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 6.25%
Explore related company data
View Iovance Biotherapeutics's market capitalizationView Iovance Biotherapeutics's price-to-book ratioView Iovance Biotherapeutics's return on equityView Iovance Biotherapeutics's dividend yieldView Iovance Biotherapeutics's 52-week price rangeView Iovance Biotherapeutics's revenue growthView Iovance Biotherapeutics's profit marginView all Iovance Biotherapeutics key metricsReturn to Iovance Biotherapeutics profile